Company Overview
American Healthcare Capital is proud to exclusively represent a dental implant manufacturer for sale. The Company is a founder-led, vertically integrated dental implant and digital dentistry platform founded in 2008. The business develops and manufactures dental implant systems, prosthetics, surgical kits, surgical tools, digital workflow solutions and intra-oral scanning products, serving more than 25 countries through a mix of distributors, subsidiaries and direct channels.
Manufacturing and Operations
Products are developed and manufactured in-house in northern Israel. The operating model is inventory-based with short delivery times, supported by a Spain warehouse for international distribution. Management is also evaluating supplemental manufacturing capability in Germany.
Sales Distribution by Country
The top disclosed revenue territories are China (33%), Israel (20%), Hungary (11%), Spain (7%) and Puerto Rico (4%), with the balance generated across other international markets.
Financial Snapshot
The Company generated $9.3 million of revenue and $2.6 million of EBITDA in 2024. Preliminary 2025 results indicate revenue of $8.4 million and EBITDA of $1.3 million, based on the year-end trial balance. Looking ahead, management projects a recovery in 2026, with revenue expected to reach $10.0 million and EBITDA of $2.0 million.
Investment Highlights
- Vertically integrated manufacturing model
- Clinician-led R&D
- Patent-protected drill-less implant concept
- Integrated digital workflow positioning
- International distributor footprint
- Clear runway for U.S. and European expansion
Transaction Overview
The shareholders are open to a majority sale, major recapitalization, minority growth investment or structured strategic partnership. Management is open to retaining ownership, rolling equity and remaining involved post-close.
Asking Price
The asking price for this opportunity is $20.0 million.